1 completed, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow Visual Impairment: new trials by email Literature Review of Visual Impairment trials Research Report on Visual Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement Metformin - Bardet-Biedl Syndrome, Visual Impairment | Phase 2 | Withdrawn | University Hospital Tuebingen | 2018-04-01 | 2019-04-18 | |
| Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema RFB002, Laser photocoagulation - Diabetic Macular Edema, Visual Impairment | Phase 2 | Completed | Novartis Pharmaceuticals | 83 | 2009-11-01 | 2017-03-03 |
Vision Disorders (2) · Bardet-Biedl Syndrome (1)
Eye Diseases (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Sensation Disorders (2) · Signs and Symptoms (2) · Abnormalities, Multiple (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Ciliopathies (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Hypothalamic Diseases (1)
Metformin (1) · Ranibizumab (1)
Novartis Pharmaceuticals (1) · University Hospital Tuebingen (1)
Spain (1)
Heiko Billing, PD Dr. med. (1)
2009 (1)